在化疗期间探索急性白血病儿童的核心症状和症状之间的相互关系:网络分析
Jia Fang1, Li-Ling Xu2, Chun-Qin Liu3
1Department of Nursing, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou, China.
概括
在接受化疗的急性白血病儿童中,担忧和易怒是关键症状. 情绪症状,特别是在老年儿童和诱导/缓解阶段,需要注意.
科学领域:
- 儿科瘤学 儿科瘤学
- 症状管理 症状管理
- 心理社会瘤学
背景情况:
- 患有急性白血病的儿童在化疗期间经历了显著的症状负担.
- 关于这些症状在儿科急性白血病中的相互联系的研究有限.
研究的目的:
- 为了确定急性白血病儿童在化疗期间经历的核心症状.
- 通过网络分析阐明这些症状之间的相互关系.
主要方法:
- 对469名患有急性白血病的儿童的数据进行了网络分析.
- 纪念症状评估尺度10-18 (MSAS 10-18) 用于评估症状的流行程度和严重程度.
- 集中度指数和网络密度被用来分析症状的相互关系.
主要成果:
- 担心和易怒被确定为基于强度,亲密度和中间的核心症状.
- 缺乏能量是最常见的,但不那么主要的症状.
- 与其他周期相比,诱导和缓解阶段的症状网络密度在诱导和缓解阶段有显著差异.
结论:
- 网络分析是了解儿科急性白血病症状集群的宝贵工具.
- 情绪症状,特别是在诱导/缓解期间和在老年儿童中,需要集中评估.
- 需要进一步的纵向研究来探索动态的症状网络和因果关系.
相关概念视频
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Disorders of Leukocytes
982
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
982
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
190
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
190
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
326
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
326
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
305
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
305
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


